We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
AUM
$181M
AUM Growth
+$37.6M
Cap. Flow
+$35M
Cap. Flow %
19.34%
Top 10 Hldgs %
79.55%
Holding
58
New
10
Increased
25
Reduced
10
Closed
2
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
26
AT&T
T
$178B
$781K 0.43%
29,262
+1,519
+5% +$40.7K
IVV icon
27
iShares Core S&P 500 ETF
IVV
$898B
$668K 0.37%
3,391
-1,336
-28% -$256K
PG icon
28
Procter & Gamble
PG
$334B
$624K 0.34%
7,936
+605
+8% +$48.8K
MCK icon
29
McKesson
MCK
$104B
$568K 0.31%
3,050
CSCO icon
30
Cisco
CSCO
$433B
$536K 0.3%
21,580
+628
+3% +$15K
VIG icon
31
Vanguard Dividend Appreciation ETF
VIG
$113B
$444K 0.25%
+5,696
New +$436K
PFE icon
32
Pfizer
PFE
$159B
$413K 0.23%
14,662
+435
+3% +$12.4K
PEP icon
33
PepsiCo
PEP
$192B
$398K 0.22%
4,459
+1
+0% +$86
MCD icon
34
McDonald's
MCD
$187B
$377K 0.21%
3,744
-140
-4% -$14.1K
MRK icon
35
Merck
MRK
$365B
$336K 0.19%
6,094
+3
+0% +$164
VZ icon
36
Verizon
VZ
$208B
$314K 0.17%
6,422
-115
-2% -$5.57K
AMZN icon
37
Amazon
AMZN
$2.87T
$308K 0.17%
18,960
+2,980
+19% +$47.1K
QCOM icon
38
Qualcomm
QCOM
$175B
$308K 0.17%
3,894
+1
+0% +$79
TEVA icon
39
Teva Pharmaceuticals
TEVA
$42.5B
$280K 0.15%
5,351
AXP icon
40
American Express
AXP
$225B
$278K 0.15%
+2,929
New +$264K
WBA
41
DELISTED
Walgreens Boots Alliance
WBA
$274K 0.15%
3,698
IBM icon
42
IBM
IBM
$222B
$256K 0.14%
1,478
+96
+7% +$17.3K
KO icon
43
Coca-Cola
KO
$386B
$251K 0.14%
+5,920
New +$240K
AMGN icon
44
Amgen
AMGN
$233B
$243K 0.13%
2,053
+2
+0.1% +$232
TWTR
45
DELISTED
Twitter, Inc.
TWTR
$243K 0.13%
+5,941
New +$225K
SLB icon
46
SLB Ltd
SLB
$84.8B
$238K 0.13%
+2,019
New +$208K
RDS.A
47
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$237K 0.13%
+3,083
New +$225K
UNP icon
48
Union Pacific
UNP
$183B
$235K 0.13%
2,352
VFH icon
49
Vanguard Financials ETF
VFH
$13.9B
$232K 0.13%
4,992
-402
-7% -$18.2K
SYK icon
50
Stryker
SYK
$127B
$228K 0.13%
2,705

Similar funds

Capital Advantage's Q2 2014 Portfolio in Review

As of Q2 2014, Capital Advantage held 58 positions worth $181M, up 26% from $144M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Capital Advantage deployed $35M of net new capital in Q2 2014, opening 10 new positions and adding to 25 existing holdings. Its largest new stake was Invesco BulletShares 2018 Corporate Bond ETF: 621,759 shares worth $13.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 86% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $5.16M trimmed.

  • Capital Advantage's largest Q2 2014 buy was Invesco BulletShares 2018 Corporate Bond ETF: 621,759 shares worth $13.2M.
  • Capital Advantage added most to Guggenheim BulletShares 2016 High Yield Corporate Bond ETF in Q2 2014, an estimated $8.5M increase.
  • Capital Advantage's biggest Q2 2014 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $5.16M.
  • Capital Advantage fully exited State Street SPDR S&P Dividend ETF in Q2 2014, selling an estimated $234K.
  • Capital Advantage's ten largest holdings make up 80% of its $181M portfolio in Q2 2014.
  • Capital Advantage opened 10 new positions and closed 2 in Q2 2014.
  • Capital Advantage's portfolio value rose 26% quarter-over-quarter to $181M.

Based on Capital Advantage's 13F filing for Q2 2014, filed 15 Jul 2016.